BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for March 12, 2026

March 12, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Biogen, Genethon, Lexicon, UCB.
Read More

Financings for March 12, 2026

March 12, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Bioxcel, Catheter Precision, Crispr, Dianthus, Emboline, Nurexone, Sandoz, Vima, Vitestro, Xenon.
Read More

Appointments and advancements for March 12, 2026

March 12, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aim Medical Robotics, Aurion, Bionexus, Certus, Cognito, Commit, Curanex, Fidelion, Mainz, Skyhawk.
Read More

Regulatory actions for March 11, 2026

March 11, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Biocartis, Capricor, Centauri, Eledon, Genfit, Incyte, Johnson & Johnson, Lenz, Mineralys, QT Imaging, Soligenix.
Read More

Other news to note for March 11, 2026

March 11, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Ardelyx, Axena, Beyond Air, Biontech, Cassava, Celularity, Cliniquantum, Dario, Erasca, Genedx, Glooko, Guardant, Joyo, Mink, Neuronos, Neurothera, Novo Nordisk, Quest, Scisparc, XLT, Zevra.
Read More

In the clinic for March 11, 2026

March 11, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Aptevo, Arcutis, Ascletis, Celcuity, Citius, Edgewise, Excellthera, Kainova, Neurosense, NMD, SAB, Satellos, Telix, Tonix, Vertex.
Read More

Financings for March 11, 2026

March 11, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Calidi, Longeveron, Max, May Health, Neuros, Theralase, Technomark, Trinity.
Read More

Appointments and advancements for March 11, 2026

March 11, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aeon, Butterfly, Dermata, H. Lundbeck, MBX, Odyssey, OSE, Qlaris, Sandoz, Santhera, Vect-Horus.
Read More

Regulatory actions for March 10, 2026

March 10, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, BMS, Chiesi, Claritas, Daiichi, Immunitybio, Incyte, Johnson & Johnson, Junshi, MBX, Nanosonics, PMV, Precision, Protalix, Sangamo, Savara.
Read More

Other news to note for March 10, 2026

March 10, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Actuate, Baymedica, DT-Axis, Eledon, Etcembly, Fujitsu, Galecto, Inmed, Kuva Labs, Kyron.bio, Lisata, Newcelx, Servier, Zelluna.
Read More
Previous 1 2 … 22 23 24 25 26 27 28 29 30 … 1790 1791 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing